Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay J Mathew

Showing results (71-80 of 190) with videos related to

Pageof 19
Sort By:
Journal of Affective Disorders|January 7, 2016
Patterns of anterior versus posterior white matter fractional anistotropy concordance in adult nonhuman primates: Effects of early life stressJeremy D Coplan, Venu Kolavennu, Chadi G Abdallah, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 12, 2025
Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depressionShabnam Hossein, Manivel Rengasamy, Aiyedun Uzamere, et al.
The American Journal of Psychiatry|June 1, 2004
Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging studySanjay J Mathew, Xiangling Mao, Jeremy D Coplan, et al.
Journal of Affective Disorders|March 26, 2021
Distinct trajectories of antidepressant response to intravenous ketamineBrittany O'Brien, Marijn Lijffijt, Jaehoon Lee, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 15, 2022
Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progressMichael D Kritzer, Nicholas A Mischel, Jonathan R Young, et al.
Biological Psychiatry|November 22, 2007
Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorderSanjay J Mathew, Rebecca B Price, Xiangling Mao, et al.
JAMA Psychiatry|March 2, 2017
A Consensus Statement on the Use of Ketamine in the Treatment of Mood DisordersGerard Sanacora, Mark A Frye, William McDonald, et al.
Journal of Psychopathology and Clinical Science|September 23, 2024
Functional connectivity subtypes during a positive mood induction: Predicting clinical response in a randomized controlled trial of ketamine for treatment-resistant depressionShabnam Hossein, Mary L Woody, Benjamin Panny, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 19, 2023
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Contemporary Clinical Trials Communications|September 12, 2019
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depressionBrittany O'Brien, Charles E Green, Rayan Al-Jurdi, et al.
Pageof 19

Showing results (71-80 of 190) with videos related to

Sort By:
Pageof 19
Journal of Affective Disorders|January 7, 2016
Patterns of anterior versus posterior white matter fractional anistotropy concordance in adult nonhuman primates: Effects of early life stressJeremy D Coplan, Venu Kolavennu, Chadi G Abdallah, et al.
The British Journal of Psychiatry : the Journal of Mental Science|May 12, 2025
Effects of ketamine on individual symptoms and symptom networks of depression in a randomised controlled trial of ketamine for treatment-resistant depressionShabnam Hossein, Manivel Rengasamy, Aiyedun Uzamere, et al.
The American Journal of Psychiatry|June 1, 2004
Dorsolateral prefrontal cortical pathology in generalized anxiety disorder: a proton magnetic resonance spectroscopic imaging studySanjay J Mathew, Xiangling Mao, Jeremy D Coplan, et al.
Journal of Affective Disorders|March 26, 2021
Distinct trajectories of antidepressant response to intravenous ketamineBrittany O'Brien, Marijn Lijffijt, Jaehoon Lee, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|February 15, 2022
Ketamine for treatment of mood disorders and suicidality: A narrative review of recent progressMichael D Kritzer, Nicholas A Mischel, Jonathan R Young, et al.
Biological Psychiatry|November 22, 2007
Hippocampal N-acetylaspartate concentration and response to riluzole in generalized anxiety disorderSanjay J Mathew, Rebecca B Price, Xiangling Mao, et al.
JAMA Psychiatry|March 2, 2017
A Consensus Statement on the Use of Ketamine in the Treatment of Mood DisordersGerard Sanacora, Mark A Frye, William McDonald, et al.
Journal of Psychopathology and Clinical Science|September 23, 2024
Functional connectivity subtypes during a positive mood induction: Predicting clinical response in a randomized controlled trial of ketamine for treatment-resistant depressionShabnam Hossein, Mary L Woody, Benjamin Panny, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 19, 2023
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Contemporary Clinical Trials Communications|September 12, 2019
Bayesian adaptive randomization trial of intravenous ketamine for veterans with late-life, treatment-resistant depressionBrittany O'Brien, Charles E Green, Rayan Al-Jurdi, et al.
Pageof 19